Published 1 month ago

EPNextS Group and Frontage Laboratories Forge Alliance to Tackle Japan's Drug Development Hurdles

Summary by Ground News

Japan's EPNextS Group and US-based Frontage Laboratories, Inc. have announced a partnership aimed squarely at overcoming Japan's notorious Drug Lag and Drug Loss issues. The two organizations hope to streamline the pathway from drug discovery to market, ensuring faster patient access to innovative therapies.

0 Articles

All

Left

Center

Right

MyChesCo

EPNextS Group and Frontage Laboratories Forge Alliance to Tackle Japan's Drug Development Hurdles

EXTON, PA — In a strategic move poised to reshape the pharmaceutical landscape, Japan’s EPNextS Group and US-based Frontage Laboratories, Inc. have announced a partnership aimed squarely at overcoming Japan’s …

1 month ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated1 month agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

EPNextS Group and Frontage Laboratories Forge Alliance to Tackle Japan's Drug Development Hurdles

0 Articles

0 Articles

EPNextS Group and Frontage Laboratories Forge Alliance to Tackle Japan's Drug Development Hurdles

EPNextS Group and Frontage Laboratories Forge Alliance to Tackle Japan's Drug Development Hurdles

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics